COMMUNIQUÉS West-GlobeNewswire

Lutronic Vision’s R:GEN™ Treats First CSC Patient at Seoul National University Hospital
17/06/2019
- Korea’s first retina treatment laser is available to treat Central Serous Chorioretinopathy - BILLERICA, Mass., June 17, 2019 (GLOBE NEWSWIRE) -- Lutronic Vision (“Lutronic” or the “Company”), a wholly-owned [...]
ContraFect Announces ASM Microbe 2019 Outstanding Abstract Award and Presentation of New Data
17/06/2019
YONKERS, N.Y., June 17, 2019 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq:CFRX) , a clinical-stage biotechnology company focused on the discovery and development of biologic therapies for life-threatening, drug- [...]
Ambu A/S: Review of the Big Five 2020 Strategy
17/06/2019
Ambu is expanding its product portfolio and commercial infrastructure. Today, we announce timelines for new aScope™ 5, a new ureteroscope, a new monitor platform that allows full HD quality and a replacement of the [...]
AIT Therapeutics Schedules Fiscal Year 2019 Financial Results Conference Call and Webcast
17/06/2019
Call scheduled for Tuesday, June 25th at 4:30pm Eastern Time GARDEN CITY, N.Y. and REHOVOT, Israel, June 17, 2019 (GLOBE NEWSWIRE) -- AIT Therapeutics, Inc. (NASDAQ: AITB), a clinical-stage medical device and [...]
iCAD Announces Closing of Public Offering of Common Stock
17/06/2019
NASHUA, N.H., June 17, 2019 (GLOBE NEWSWIRE) -- iCAD, Inc. (“iCAD”) (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, announced today the closing of its [...]
Transparency notification
17/06/2019
Mechelen, Belgium; 17 June 2019; 22.01 CET; regulated information - Galapagos NV (Euronext & NASDAQ: GLPG) received a transparency notification from The Capital Group Companies, Inc . Pursuant to Belgian [...]
PhaseBio Announces Positive Preliminary Results from Phase 2a Clinical Trial of PB2452 for the Reversal of the Antiplatelet Activity of Ticagrelor in Older and Elderly Subjects
17/06/2019
Top-Line Data Are Consistent with Previously Published Phase 1 Trial MALVERN, Pa. and SAN DIEGO, June 17, 2019 (GLOBE NEWSWIRE) -- PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical [...]
Rockwell Medical Announces Proposed Public Offering of Common Stock
17/06/2019
WIXOM, Mich., June 17, 2019 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ:RMTI) (“Rockwell Medical” or the “Company”), a biopharmaceutical company dedicated to improving outcomes for patients with anemia, with an [...]
Calithera Biosciences, Inc. Announces Commencement of Underwritten Public Offering of Common Stock
17/06/2019
SOUTH SAN FRANCISCO, Calif., June 17, 2019 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical stage biotechnology company focused on discovering and developing novel small molecule drugs for the [...]
Delta 9 Announces Public Offering of Convertible Debenture Units
17/06/2019
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. WINNIPEG, Manitoba, June 17, 2019 (GLOBE NEWSWIRE) -- Delta 9 Cannabis Inc. (“ Delta 9 ” or the “ Company ”) (TSXV: NINE [...]
BioSyent to Present at Raymond James Life Sciences and MedTech Conference
17/06/2019
TORONTO, June 17, 2019 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) is pleased to announce that Mr. René Goehrum, President and CEO of BioSyent, will be presenting at the 2019 Raymond James Life [...]
Seminal Clinical Trial in Healthy Adults Demonstrates Promising Preliminary Evidence of PlusCBD™ Oil in Sleep, Wellness, and Weight-Loss Applications
17/06/2019
First-Ever Double-Blind, Randomized Study Titled, “Effects of a CBD-containing Supercritical Fluid Extract of Hemp on Markers of Optimal Wellness, Stress Resilience, and Recovery in Healthy Subjects,” Validates Benefits [...]
Private placement fully subscribed
17/06/2019
BioPorto A/S Other information disclosed according to the rules of the Exchange June 17, 2019 Announcement no. 9 Private placement fully subscribed With reference to company announcement no. 8 of 17 June 2019, the Board [...]
IBA - Transparency Notification
17/06/2019
Louvain-la-Neuve, Belgium, June 17, 2019, 17.35 Summary of the notification IBA (Ion Beam Applications SA), the world’s leading provider of proton therapy solutions for the treatment of cancer, announces that it has to [...]
IBA - Publication relative à une notification de transparence
17/06/2019
Louvain-la-Neuve, Belgique, 17 juin 2019, 17.35 Résumé de la notification IBA (Ion Beam Applications SA), le premier fournisseur mondial de solutions de protonthérapie pour le traitement du cancer, annonce devoir [...]
Sanofi: information concerning the total number of voting rights and shares, May 2019
17/06/2019
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement général de l’ [...]
Sanofi : informations relatives au nombre total de droits de vote et d’actions, mai 2019
17/06/2019
Informations relatives au nombre total de droits de vote et d’actions prévues par l’article L. 233-8 II du Code de commerce et l’article 223-16 du Règlement général de l’Autorité des Marchés Financiers Sanofi Société [...]
BioPorto A/S to Increase its Share Capital through a Cash Issue, Private Placement
17/06/2019
June 17, 2019 Announcement no. 8 BioPorto A/S to Increase its Share Capital through a Cash Issue, Private Placement NOT FOR RELEASE , PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, [...]
Ossur Hf : Transactions in relation to share buyback program
17/06/2019
Announcement no. 37/2019 17 June 2019 Transactions in relation to share buyback program On 14 May 2019, Össur hf. initiated a share buy-back program, see Company announcement no. 31/2019. The purpose of the share [...]

Pages